CPT 80369 Skeletal Muscle Relaxant Assay Reimbursement

CPT code 80369 denotes a laboratory assay to measure or detect one or two skeletal muscle relaxants in a patient specimen. This test supports clinical management of patients receiving muscle relaxants by identifying therapeutic levels, subtherapeutic dosing, or toxic concentrations that affect muscle tone and pain control. Nationally, such testing matters for patient safety, medication monitoring, and appropriate utilization of laboratory toxicology services.

Key payers in coverage and payment discussions include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context, typical sites of service, and payer considerations. The publication provides benchmarks for utilization and payment trends where available, summarizes relevant policy updates affecting laboratory drug assay billing, and outlines common clinical scenarios that prompt ordering of this test.

The content is intended for health system administrators, laboratory managers, and billing professionals seeking a national-level summary of CPT code 80369, its clinical role, and the payer landscape. Data not available in the input will be noted where applicable in detailed sections.

Billing Code Overview

CPT code 80369 measures the amount of or detects the presence of one or two skeletal muscle relaxants in a patient specimen. These agents reduce skeletal muscle tone to relieve muscle spasm and pain. The test is a clinical laboratory service performed by a lab analyst using biochemical or instrumental techniques to identify and quantify therapeutic or toxic levels of muscle relaxant drugs.

Service Type: Drug assay / toxicology testing

Typical Site of Service: Clinical laboratory or hospital outpatient laboratory setting for specimens collected in ambulatory clinics, emergency departments, or inpatient units.

Clinical Context

A 45-year-old patient with severe lower back spasm presents to an outpatient laboratory after an emergency department visit where oral or parenteral skeletal muscle relaxant therapy was initiated. The clinician orders a specimen-level toxicology assay to detect or quantitate one or two skeletal muscle relaxants to confirm therapeutic drug levels, assess adherence, identify potential overdose, or evaluate unexpected sedation or respiratory depression. The specimen (typically serum or plasma, occasionally urine) is collected in the lab, labeled, and transported to a clinical chemistry/toxicology laboratory. A medical technologist or laboratory analyst performs the targeted assay using mass spectrometry or immunoassay to detect agents such as cyclobenzaprine or baclofen. Results are reviewed by laboratory staff, reported to the ordering provider, and integrated into the patient’s record to guide ongoing management, e.g., dose adjustment, observation for toxicity, or further diagnostic testing. Typical site of service is an outpatient clinical laboratory or hospital laboratory supporting emergency department and inpatient care.

Coding Specifications

Modifier	Description	When to Use
`26`	Professional component	Use when only the laboratory professional's interpretation/report component is billed separately from technical services.
`TC`

Taxonomy Code	Specialty	Notes
2085P0200X	Clinical Chemistry	Laboratory directors and clinical chemists performing/overseeing toxicology assays.
207R00000X	Anatomic and Clinical Pathology	Pathologists who interpret and oversee laboratory testing and reporting.
174400000X	Emergency Medicine	Emergency physicians who order targeted skeletal muscle relaxant testing for acute toxicity or overdose.
207L00000X	Medical Toxicology	Medical toxicologists advising on interpretation of results and clinical management.
261QM0800X	Pain Medicine	Pain specialists who may order drug level testing to assess adherence, therapeutic monitoring, or adverse effects.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`T43.592A`	Poisoning by other and unspecified antipsychotics, initial encounter	Some skeletal muscle relaxant overdoses may be coded with poisoning codes when acute toxicity is present; used when clinical presentation indicates poisoning.
`T43.592S`	Poisoning by other and unspecified antipsychotics, sequela	Used when late effects of poisoning require assessment, including testing for persistent levels.
`G43.909`	Migraine, unspecified, not intractable, without status migrainosus	Muscle relaxants are sometimes used adjunctively for tension-type headaches or muscle-related headache contributors; testing may be ordered if adverse effects suspected.
`M54.5`	Low back pain	Common indication for prescribing skeletal muscle relaxants; testing may evaluate adherence or toxicity in patients with persistent symptoms.
`F11.20`	Opioid dependence, uncomplicated	Co-prescribed muscle relaxants and opioids increase risk of sedation/overdose; testing for muscle relaxants may be part of substance use monitoring.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`80369`	Drug assay, qualitative or quantitative, single or multiple drugs, skeletal muscle relaxants, one or two analytes	Primary code describing targeted laboratory detection/measurement of one or two skeletal muscle relaxants.
`80307`	Drug screen, qualitative; multiple drug classes by high complexity test methods	May be performed alongside to screen broader drug classes when polysubstance use or alternate agents are suspected.
`82542`	Drug assay, presumptive, oral fluid or saliva, each drug class	Alternative specimen type assays; occasionally used if blood/urine not available.
`80320`	Drug confirmation, definitive, qualitative/quantitative, single drug class by mass spectrometry	Performed when confirmatory identification or quantitation is required beyond the initial assay, such as for legal or definitive toxicology.
`36415`	Collection of venous blood by venipuncture	Specimen collection code typically used prior to running the assay on serum/plasma.

OpenPayer

Summary & Overview

CPT 80369: Skeletal Muscle Relaxant Assay